Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.
Published
See what other members have to say:
"Very useful, I have filled many gaps and gained practical knowledge."
"I feel now more confident in diagnosing the presented conditions. Really it is one of the best learning activities I have completed recently."
No comments yet.